Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis
出版年份 2020 全文链接
标题
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and cancer a meta-analysis
作者
关键词
-
出版物
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-10-12
DOI
10.1007/s11239-020-02304-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
- (2020) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis
- (2020) Michela Giustozzi et al. THROMBOSIS AND HAEMOSTASIS
- Factor Xa inhibitors in the prevention of cancer-related venous thromboembolism: lessons learned by clinical trials
- (2020) Carlo Lavalle et al. Future Oncology
- Oral Anticoagulants in Japanese Patients with Atrial Fibrillation and Active Cancer
- (2019) Taku Yasui et al. INTERNAL MEDICINE
- Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta‐Analysis
- (2019) Yuqing Deng et al. Journal of the American Heart Association
- Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
- (2019) Robert D. McBane et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
- (2019) Dominique Farge et al. LANCET ONCOLOGY
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Arterial thrombosis and cancer
- (2018) Doron Aronson et al. THROMBOSIS RESEARCH
- Impact of atrial fibrillation on the development of ischemic stroke among cancer patients classified by CHA2DS2-VASc score-a nationwide cohort study
- (2018) Wei-Syun Hu et al. Oncotarget
- Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
- (2018) Kyu Kim et al. Korean Circulation Journal
- Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial
- (2018) Christina L. Fanola et al. Journal of the American Heart Association
- How I treat cancer-associated venous thromboembolism
- (2018) Noémie Kraaijpoel et al. BLOOD
- Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study
- (2017) Anne G. Ording et al. Cancer Medicine
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPACE
- Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy
- (2016) Yong-Joon Lee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Bleeding complications during anticoagulant treatment in patients with cancer
- (2014) Pieter W. Kamphuisen et al. THROMBOSIS RESEARCH
- Venous Thromboembolism and Cancer
- (2013) Gregory Piazza CIRCULATION
- Worldwide Epidemiology of Atrial Fibrillation
- (2013) Sumeet S. Chugh et al. CIRCULATION
- Insights Into Onco-Cardiology
- (2013) Dimitrios Farmakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias
- (2010) Karsten Knobloch et al. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More